Main Navigation

Quick Links

Recursion signs partnership that could net company billions

Recursion on NasDaq electronic billboard

Recursion Pharmaceuticals Inc. has announced it has formed a drug-discovery collaboration with Swiss drug and diagnostics giant Roche AG, and its U.S. subsidiary Genentech, that is potentially worth several billion dollars to the Salt Lake City-based clinical-stage biotechnology company in the next 10 years.

Recursion said it will work with the research and development units of both Roche and Genentech to use its Recursion Operating System to more rapidly identify novel targets and advance medicines in key areas of neuroscience, as well as in an oncology indication.

Read the full article here.

Oh, hello!

Contact Form